PolyPid Ltd
PYPD
查看詳細走勢圖
4.520USD
+0.170+3.91%
收盤 02/06, 16:00（美東）報價延遲15分鐘
75.19M總市值
虧損本益比TTM
盤中分時
1分
30分
1小時
日k
週k
月k
日k
今天
+3.91%
5天
-1.31%
1月
-1.09%
6月
+38.65%
今年開始到現在
+4.15%
1年
+55.86%
查看詳細走勢圖
TradingKey 股票評分
由於缺少必要的數據，暫時無法對該公司進行評分
PolyPid Ltd新聞
即將為您帶來更多新聞，敬請期待。 。 。
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
PolyPid Ltd簡介
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.
公司代碼PYPD
公司PolyPid Ltd
CEOAkselbrad (Dikla Czaczkes)
網址https://www.polypid.com
相關品種
+3.66%
+3.14%
+0.93%
+2.01%
+1.82%
+1.60%
-0.95%
+4.49%
+2.10%
+9.92%
+2.76%
+4.15%
+1.79%
+4.17%
+0.72%
+1.10%
+2.46%
0.00%
+0.51%
+0.54%熱門品種
278.120
+2.210 (+0.80%)
185.410
+13.530 (+7.87%)
71188.090
+1217.960 (+1.74%)
282.580
+22.390 (+8.61%)
2101.660
+49.930 (+2.43%)
411.110
+13.900 (+3.50%)
4952.980
+142.360 (+2.96%)
63.303
+0.206 (+0.33%)
1.182
+0.004 (+0.35%)
157.098
+0.057 (+0.04%)
